Get the Stockscreener App
1.01
0.00%
0.00
After Hours:
1.04
0.03
+2.97%
Oncolytics Biotech Inc stock is traded at $1.01, with a volume of 725.63K.
It is up +0.00% in the last 24 hours and down -25.74% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.01
Open:
$0.99
24h Volume:
725.63K
Relative Volume:
0.70
Market Cap:
$101.36M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-3.8185
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
-12.93%
1M Performance:
-25.74%
6M Performance:
+98.04%
1Y Performance:
-9.82%
1-Day Range:
$0.9818
$1.05
1-Week Range:
$0.92
$1.19
52-Week Range:
$0.3258
$1.51
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.01 | 105.57M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.25 | 105.80B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
646.87 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
440.49 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.01 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.68 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Will Oncolytics Biotech Inc. outperform the marketJuly 2025 Trends & Safe Entry Zone Tips - newser.com
Will Oncolytics Biotech Inc. stock keep outperforming rivalsJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
Combining price and volume data for Oncolytics Biotech Inc.Weekly Stock Recap & AI Driven Price Predictions - newser.com
How to interpret RSI for Oncolytics Biotech Inc. stockPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Identifying reversal signals in Oncolytics Biotech Inc.2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
What recovery options are there for Oncolytics Biotech Inc.2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Using Ichimoku Cloud for Oncolytics Biotech Inc. technicalsJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
Heatmap analysis for Oncolytics Biotech Inc. and competitorsJuly 2025 Review & Daily Technical Forecast Reports - newser.com
What margin trends mean for Oncolytics Biotech Inc. stockJuly 2025 Action & Verified Entry Point Detection - newser.com
Why analysts remain bullish on Oncolytics Biotech Inc. stockQuarterly Market Summary & Free High Return Stock Watch Alerts - newser.com
Will Oncolytics Biotech Inc. stock recover faster than peersPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Backtesting results for Oncolytics Biotech Inc. trading strategiesStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Can Oncolytics Biotech Inc. stock rebound after recent weaknessGap Down & Low Drawdown Momentum Ideas - newser.com
What dividend safety score for Oncolytics Biotech Inc. stockJuly 2025 Update & Daily Chart Pattern Signals - newser.com
Can Oncolytics Biotech Inc. stock maintain growth trajectory2025 Trade Ideas & Weekly Sector Rotation Insights - fcp.pa.gov.br
Oncolytics Biotech (ONCY) to Release Earnings on Tuesday - MarketBeat
Why Oncolytics Biotech Inc. is moving today2025 Earnings Impact & Technical Analysis for Trade Confirmation - newser.com
How to monitor Oncolytics Biotech Inc. with trend dashboardsWall Street Watch & Long-Term Investment Growth Plans - newser.com
Using data tools to time your Oncolytics Biotech Inc. exit2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Is Oncolytics Biotech Inc. stock gaining market shareQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy - BioSpace
Oncolytics Biotech forms GI cancer scientific advisory board By Investing.com - Investing.com South Africa
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Oncolytics Biotech Forms Advisory Board to Advance GI Cancer Treatment - TipRanks
Oncolytics Biotech forms GI cancer scientific advisory board - Investing.com
Oncolytics (NASDAQ: ONCY) forms GI SAB with 3 initial members to guide registration - Stock Titan
Visual trend scoring systems applied to Oncolytics Biotech Inc.Bear Alert & Verified Trade Idea Suggestions - newser.com
Will Oncolytics Biotech Inc. stock reach Wall Street targets2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Is Oncolytics Biotech Inc. stock overvalued by current metrics2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):